We serve Chemical Name:3-(3-Bromophenyl)pyridine CAS:4422-32-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-(3-Bromophenyl)pyridine
CAS.NO:4422-32-6
Synonyms:Pyridine, 3-(3-bromophenyl)-;3-(3-Bromophenyl)pyridine
Molecular Formula:C11H8BrN
Molecular Weight:234.092
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:321.3±17.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.606
PSA:12.89000
Exact Mass:232.984009
LogP:3.34
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Pyridine, 3-(3-bromophenyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(3-Bromophenyl)pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyridine, 3-(3-bromophenyl)- Use and application,3-(3-Bromophenyl)pyridine technical grade,usp/ep/jp grade.
Related News: Such investment is by no means prohibitive and can reap substantial rewards that include shorter development timelines, lower costs, faster time to market, and game changing technological advantage for sustainable competitive edge. 1-(dichloromethyl)-9H-β-carboline-3-carboxylic acid manufacturers India and China are two of the leading players in that game, and US legislators for months have pushed for an aggressive “onshoring” of drug production to counteract the nation’s reliance on foreign producers. Israel, a key ally to the US, could be a logical partner in that effort, but the Trump administration also took out big bets on US firms to set up shop stateside. 2-(4-chlorophenoxymethyl)thio-5-chloropyrimidine suppliers This further investment in enhanced facilities and continuous staff development provides the increased range of testing services required by the international biopharmaceutical industry. 2H-Azepin-2-one, hexahydro-7-[(2E)-1-oxo-3-phenyl-2-propenyl]- vendor & factory Such investment is by no means prohibitive and can reap substantial rewards that include shorter development timelines, lower costs, faster time to market, and game changing technological advantage for sustainable competitive edge. ,He joins us at a pivotal time as our Jinkō® platform goes from strength to strength as we expand our portfolio of partnerships. Grégoire’s strategic and operational expertise will be a vital part of our future success in accelerating and de-risking clinical trials.
